5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 48.66▲ | 48.38▲ | 48.31▲ | 48.66▲ | 50.82▼ |
MA10 | 48.53▲ | 48.16▲ | 48.18▲ | 49.68▼ | 54.75▼ |
MA20 | 48.46▲ | 48.14▲ | 48.12▲ | 51.43▼ | 63.34▼ |
MA50 | 48.22▲ | 48.13▲ | 49.40▼ | 58.09▼ | 68.07▼ |
MA100 | 48.14▲ | 49.51▼ | 50.46▼ | 64.82▼ | 75.28▼ |
MA200 | 48.10▲ | 50.72▼ | 52.42▼ | 66.28▼ | 74.80▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.020▲ | 0.095▲ | 0.160▲ | 0.095▲ | -1.818▼ |
RSI | 67.235▲ | 63.282▲ | 54.174▲ | 31.717▼ | 31.548▼ |
STOCH | 89.535▲ | 79.840 | 67.111 | 21.142 | 7.260▼ |
WILL %R | -2.222▲ | -0.862▲ | -0.862▲ | -78.743▼ | -95.646▼ |
CCI | 120.201▲ | 160.895▲ | 211.429▲ | -107.744▼ | -84.513 |
Sunday, September 28, 2025 11:53 PM
BioCryst Pharmaceuticals is highlighted for its strong potential, driven by its approved therapy ORLADEYO. Read why BCRX stock is a Buy.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 48.42 | 48.75 | 47.59 | 48.74 | 520,258 |
29/09/25 | 48.42 | 48.46 | 47.79 | 48.12 | 752,400 |
26/09/25 | 47.76 | 48.29 | 47.32 | 48.17 | 932,200 |
25/09/25 | 50.48 | 50.645 | 47.38 | 47.67 | 1,459,200 |
24/09/25 | 50.57 | 51.625 | 50.44 | 50.61 | 563,958 |
23/09/25 | 51.11 | 51.96 | 50.59 | 50.65 | 934,273 |
22/09/25 | 50.45 | 51.615 | 50.01 | 51.18 | 925,796 |
19/09/25 | 51.15 | 51.50 | 50.29 | 50.60 | 2,858,715 |
18/09/25 | 50.24 | 51.44 | 50.07 | 51.15 | 1,468,400 |
17/09/25 | 51.14 | 51.31 | 49.45 | 49.95 | 1,465,074 |
|
|
||||
|
|
||||
|
|